Guests: Steven Nissen RSS

2007:

  1. The Charlie Rose Science Series: Heart Disease
    Duration
    54 min
    Comments
    23 comments
    Rating
    * * * *
  2. Childhood obesity and heart disease
    Duration
    46 sec
    Comments
    Rating
  3. Symptoms of heart disease
    Duration
    53 sec
    Comments
    Rating
  4. The future of preventative cardiology Part I
    Duration
    2 min
    Comments
    Rating
  5. The future of regenerative heart muscle
    Duration
    55 sec
    Comments
    Rating

Steven Nissen is a heart specialist and chairman of cardiovascular medicine at the Cleveland Clinic.

He first gained prominence when he developed techniques in 1987 to thread miniaturized ultrasound imaging devices into a patient’s heart to reveal the exact composition of plaques causing the early stages of artery damage. This allowed much easier evaluation of anticholesterol medications.

His efforts in 2004 linked COX-2 inhibitors such as Celebrex and Merck’s Vioxx with heart attacks, and prevented Merck’s similar product, Arcoxia, from being approved. In 2005, he attacked the experimental diabetes drug Pargluva, from Bristol-Myers Squibb, for its serious heart risks. A Food and Drug Administration advisory panel had strongly recommended approval, but Pargluva was withdrawn. Source - http://en.wikipedia.org/wiki/Steven_Nissen